Imidazoles as potential anticancer agents

I Ali, MN Lone, HY Aboul-Enein - MedChemComm, 2017 - pubs.rsc.org
Cancer is a black spot on the face of humanity in this era of science and technology.
Presently, several classes of anticancer drugs are available in the market, but issues such …

Comprehensive review in current developments of imidazole‐based medicinal chemistry

L Zhang, XM Peng, GLV Damu… - Medicinal research …, 2014 - Wiley Online Library
Imidazole ring is an important five‐membered aromatic heterocycle widely present in natural
products and synthetic molecules. The unique structural feature of imidazole ring with …

Challenges and Opportunities in the Crusade of BRAF Inhibitors: From 2002 to 2022

AK Singh, P Sonawane, A Kumar, H Singh… - ACS …, 2023 - ACS Publications
Serine/threonine-protein kinase B-Raf (BRAF; RAF= rapidly accelerated fibrosarcoma) plays
an important role in the mitogen-activated protein kinase (MAPK) signaling cascade …

Targeting CRAF kinase in anti-cancer therapy: progress and opportunities

P Wang, K Laster, X Jia, Z Dong, K Liu - Molecular Cancer, 2023 - Springer
The RAS/mitogen-activated protein kinase (MAPK) signaling cascade is commonly
dysregulated in human malignancies by processes driven by RAS or RAF oncogenes …

Design, synthesis, and biological evaluation of novel imidazole derivatives possessing terminal sulphonamides as potential BRAFV600Eáinhibitors

EMH Ali, MS Abdel-Maksoud, UM Ammar, KI Mersal… - Bioorganic …, 2021 - Elsevier
Abstract BRAF V600E mutation has been detected in various malignant tumours.
Developing of potent BRAF V600E inhibitors is considered a leading step in the way to cure …

Recent advances of RAF (rapidly accelerated fibrosarcoma) inhibitors as anti-cancer agents

UM Ammar, MS Abdel-Maksoud, CH Oh - European Journal of Medicinal …, 2018 - Elsevier
Frequent oncogenic mutations have been identified in MAPK (mitogen-activated protein
kinase) signaling pathway components. As a result, MAPK pathway is associated with …

New diarylureas and diarylamides containing 1, 3, 4-triarylpyrazole scaffold: synthesis, antiproliferative evaluation against melanoma cell lines, ERK kinase inhibition …

WK Choi, MI El-Gamal, HS Choi, D Baek… - European journal of …, 2011 - Elsevier
Synthesis of a new series of diarylureas and diarylamides possessing 1, 3, 4-triarylpyrazole
scaffold is described. Their in vitro antiproliferative activities against 9 human melanoma cell …

Recent development of imidazole derivatives as potential anticancer agents

N Kumar, N Goel - Physical Sciences Reviews, 2023 - degruyter.com
Cancer, one of the key health problems globally, is a group of related diseases that share a
number of characteristics primarily the uncontrolled growth and invasive to surrounding …

Design and synthesis of new imidazo [1, 2-a] pyridine and imidazo [1, 2-a] pyrazine derivatives with antiproliferative activity against melanoma cells

R Garamvoelgyi, J Dobos, A Sipos, S Boros… - European journal of …, 2016 - Elsevier
Melanoma is an aggressive form of skin cancer and it is generally associated with poor
prognosis in patients with late-stage disease. Due to the increasing occurrence of …

A new series of diarylamides possessing quinoline nucleus: synthesis, in vitro anticancer activities, and kinase inhibitory effect

MI El-Gamal, MA Khan, MS Abdel-Maksoud… - European Journal of …, 2014 - Elsevier
Synthesis of a new series of diarylamides possessing 6, 7-dimethoxy (dihydroxy) quinoline
scaffold is described. Their in vitro antiproliferative activities against NCI-58 human cancer …